Stay up to date on latest news.

Sign up here to receive instant email alerts of latest news releases.

Lotus Ventures: Appointment of David Hyde as Adviser to the Company

May 16, 2018

The Company has appointed David Hyde of David Hyde & Associates as an adviser to the company. In addition, David will continue in his role as consultant on the company’s late stage license application before Health Canada. We are delighted to have David remain involved in our exciting future, as h…

Read more

Lotus Ventures Gets Confirmation of Readiness From Health Canada

April 23, 2018

Health Canada License Update Lotus Ventures Inc. (“Lotus” or the “Company”) has achieved a major milestone with the receipt from Health Canada of the Confirmation of Readiness for a License Under the Access to Cannabis Regulations (ACMPR). This represents acceptance of our detailed applic…

Read more

Lotus Ventures: Grant of Options

March 20, 2018

The Company has granted 1,490,000 stock options to eligible persons. The options can be exercised at $0.50 per share for ten years.ON BEHALF OF THE BOARDLotus Ventures Inc.“Dale McClanaghan”Dale McClanaghan, President and CEOAbout Lotus Ventures, Inc.Lotus is a late stage licensed produc…

Read more

Lotus – Enters “Active Review” with Health Canada & Closes Cannabis Financing of $1 Million

February 9, 2018

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Lotus Ventures Inc (CSE: J) (the “Company”) announced today that its licensed producer application for its Armstrong, BC purpose-built indoor facility (the “Application”) under the Access to Ca…

Read more

Lotus Ventures – Closing of Cannabis Financing of $5 Million; Solidifying Expansion Capital

January 22, 2018

The Company has closed its financing for gross proceeds of $5,018,050 (10,036,100 units). Each unit contains one common share at $0.50 and one five-year share purchase warrant exercisable at a price of $0.70. The issue was initially announced November 17, 2017 targeting a raise of $1,000,000 and has…

Read more

Show all